Zidovudine 300 mg
One of the first antiretroviral agents introduced into clinical practice, Zidovudine 300 mg Tablets are a nucleoside reverse transcriptase inhibitor used in combination regimens to manage HIV-1 infection under established treatment guidelines.
Product Details
Therapeutic Class
Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg twice daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 tablets